PKM and neoplasm: Importantly, TEPP-46 treatment attenuated the expression of HIF-1α, HK2, and PKM2, an diminished glycolysis, STING phosphorylation, and type I IFN induction in tumor-infiltrating WT DCs (Figure 7, H–J).